Advisors Asset Management’s Arena Pharmaceuticals Inc ARNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-25,680
| Closed | -$2.39M | – | 1555 |
|
|
2021
Q4 | $2.39M | Buy |
25,680
+827
| +3% | +$54.5K | 0.03% | 547 |
|
|
2021
Q3 | $1.48M | Sell |
24,853
-4,558
| -15% | -$269K | 0.02% | 689 |
|
|
2021
Q2 | $2.01M | Sell |
29,411
-1,882
| -6% | -$123K | 0.03% | 599 |
|
|
2021
Q1 | $2.17M | Buy |
31,293
+1,130
| +4% | +$87K | 0.03% | 568 |
|
|
2020
Q4 | $2.32M | Buy |
30,163
+5,873
| +24% | +$440K | 0.04% | 490 |
|
|
2020
Q3 | $1.82M | Buy |
24,290
+9,011
| +59% | +$601K | 0.03% | 500 |
|
|
2020
Q2 | $962K | Sell |
15,279
-497
| -3% | -$27.3K | 0.02% | 702 |
|
|
2020
Q1 | $663K | Sell |
15,776
-8,148
| -34% | -$374K | 0.02% | 735 |
|
|
2019
Q4 | $1.09M | Sell |
23,924
-2,202
| -8% | -$104K | 0.02% | 735 |
|
|
2019
Q3 | $1.2M | Buy |
26,126
+6,042
| +30% | +$340K | 0.02% | 691 |
|
|
2019
Q2 | $1.18M | Buy |
20,084
+2,185
| +12% | +$113K | 0.02% | 723 |
|
|
2019
Q1 | $802K | Sell |
17,899
-503
| -3% | -$23.1K | 0.01% | 904 |
|
|
2018
Q4 | $717K | Sell |
18,402
-860
| -4% | -$33.8K | 0.01% | 877 |
|
|
2018
Q3 | $886K | Buy |
19,262
+4,679
| +32% | +$190K | 0.01% | 878 |
|
|
2018
Q2 | $636K | Buy |
14,583
+11,747
| +414% | +$505K | 0.01% | 980 |
|
|
2018
Q1 | $110K | Buy |
2,836
+2,318
| +447% | +$90.2K | ﹤0.01% | 1308 |
|
|
2017
Q4 | $18K | Buy |
+518
| New | +$14.8K | ﹤0.01% | 1453 |
|
Advisors Asset Management's ARNA Position: Q1 2022 in Review
Advisors Asset Management sold out of Arena Pharmaceuticals Inc (ARNA) in Q1 2022, closing a stake of 25,680 shares — an estimated $2.39M sold.
Advisors Asset Management first reported a position in ARNA in Q4 2017 and held it in 17 quarters. The position peaked at $2.39M in Q4 2021. 1 fund tracked by Wall St. Rank holds ARNA as of Q1 2022.
- Advisors Asset Management reported no remaining Arena Pharmaceuticals Inc position as of Q1 2022 after selling out during the quarter.
- Advisors Asset Management sold 25,680 Arena Pharmaceuticals Inc shares in Q1 2022, an estimated $2.39M.
- Advisors Asset Management first reported a position in Arena Pharmaceuticals Inc in Q4 2017 and held it in 17 quarters.
- Advisors Asset Management's Arena Pharmaceuticals Inc position peaked at $2.39M in Q4 2021.
- 1 fund tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q1 2022.
Based on Advisors Asset Management's 13F filing for Q1 2022, filed 17 May 2022.